Inhibition of myeloid cell leukemia-1: Association with sorafenib-induced apoptosis in human mucoepidermoid carcinoma cells and tumor xenograft
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Hyun-Ju | - |
dc.contributor.author | Shin, Ji-Ae | - |
dc.contributor.author | Jung, Ji-Youn | - |
dc.contributor.author | Nam, Jeong-Seok | - |
dc.contributor.author | Hong, In-Sun | - |
dc.contributor.author | Cho, Nam-Pyo | - |
dc.contributor.author | Cho, Sung-Dae | - |
dc.date.available | 2020-02-28T08:42:38Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-09 | - |
dc.identifier.issn | 1043-3074 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10196 | - |
dc.description.abstract | BackgroundThe purpose of our study was to investigate the anticancer effect of sorafenib on mucoepidermoid carcinoma (MEC) and find its new molecular mechanism. MethodsThe apoptotic effects of sorafenib were performed using MTS assay, diamidino-phenylindole (DAPI) staining, Western blotting, reverse transcription-polymerase chain reaction (RT-PCR), siRNA, and xenograft. ResultsSorafenib had apoptotic effects on MC-3 and YD15 cells and decreased myeloid cell leukemia-1 (Mcl-1) through proteasome-dependent protein degradation and the inhibition of protein synthesis. Sorafenib significantly affected truncated bid (t-Bid) and siMcl-1 resulting in the upregulation of t-Bid to induce apoptosis. Signal transducer and activator of transcription 3 (STAT3) phosphorylation was also blocked by sorafenib and a potent STAT3 inhibitor, cryptotanshinone clearly induced poly ADP-ribose polymerase (PARP) cleavage by inhibiting Mcl-1 and increasing t-Bid. Finally, administration of sorafenib significantly suppressed tumor growth and induced apoptosis in tumor xenograft model in association with downregulation of Mcl-1 without any side effects. ConclusionTaken together, these findings suggest that sorafenib can be a good anticancer drug candidate for the treatment of MEC. (c) 2014 Wiley Periodicals, Inc. Head Neck 37: 1326-1335, 2015 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.relation.isPartOf | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | - |
dc.subject | PROSTATE-CANCER CELLS | - |
dc.subject | DOWN-REGULATION | - |
dc.subject | HEPATOCELLULAR-CARCINOMA | - |
dc.subject | MCL-1 EXPRESSION | - |
dc.subject | LUNG-CANCER | - |
dc.subject | CONSTITUTIVE ACTIVATION | - |
dc.subject | MULTIKINASE INHIBITOR | - |
dc.subject | RAF/MEK/ERK PATHWAY | - |
dc.subject | MEDIATED APOPTOSIS | - |
dc.subject | ANTITUMOR-ACTIVITY | - |
dc.title | Inhibition of myeloid cell leukemia-1: Association with sorafenib-induced apoptosis in human mucoepidermoid carcinoma cells and tumor xenograft | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000359605700018 | - |
dc.identifier.doi | 10.1002/hed.23749 | - |
dc.identifier.bibliographicCitation | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, v.37, no.9, pp.1326 - 1335 | - |
dc.identifier.scopusid | 2-s2.0-84939000329 | - |
dc.citation.endPage | 1335 | - |
dc.citation.startPage | 1326 | - |
dc.citation.title | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | - |
dc.citation.volume | 37 | - |
dc.citation.number | 9 | - |
dc.contributor.affiliatedAuthor | Hong, In-Sun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | mucoepidermoid carcinoma | - |
dc.subject.keywordAuthor | sorafenib | - |
dc.subject.keywordAuthor | apoptosis | - |
dc.subject.keywordAuthor | myeloid cell leukemia-1 (Mcl-1) | - |
dc.subject.keywordAuthor | signal transducer and activator of transcription 3 (STAT3) | - |
dc.subject.keywordPlus | PROSTATE-CANCER CELLS | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | MCL-1 EXPRESSION | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | CONSTITUTIVE ACTIVATION | - |
dc.subject.keywordPlus | MULTIKINASE INHIBITOR | - |
dc.subject.keywordPlus | RAF/MEK/ERK PATHWAY | - |
dc.subject.keywordPlus | MEDIATED APOPTOSIS | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.relation.journalResearchArea | Otorhinolaryngology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Otorhinolaryngology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.